Genovis Investor Relations » Press Releases

Latest Releases

Genovis announces exclusive license agreement with Selecta Bioscience to develop and promote a novel IgG Protease in Gene Therapy and Autoimmune Disease [regulatory release]2021-10-21 14:00 (CEST)
Genovis AB (publ.) hires new CFO [regulatory release]2021-10-06 08:35 (CEST)
Genovis and GlycoT Therapeutics enter into cross-licensing agreements on novel antibody conjugation technology [regulatory release]2021-06-07 15:02 (CEST)

2021

Genovis announces exclusive license agreement with Selecta Bioscience to develop and promote a novel IgG Protease in Gene Therapy and Autoimmune Disease [regulatory release]2021-10-21 14:00 (CEST)
Genovis AB (publ.) hires new CFO [regulatory release]2021-10-06 08:35 (CEST)
Genovis and GlycoT Therapeutics enter into cross-licensing agreements on novel antibody conjugation technology [regulatory release]2021-06-07 15:02 (CEST)
Communiqué from Genovis AB (publ) Annual General Meeting May 20, 2021 [regulatory release]2021-05-20 11:09 (CEST)
Genovis Annual Report 2020 published [regulatory release]2021-04-28 08:02 (CEST)
NOTICE CONVENING THE 2021 ANNUAL GENERAL MEETING [regulatory release]2021-04-14 13:32 (CEST)
Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization [regulatory release]2021-04-13 14:02 (CEST)
Genovis CFO has resigned [regulatory release]2021-03-29 20:09 (CEST)
Proposal to expand the Genovis Board of Directors at 2021 AGM [regulatory release]2021-03-02 08:51 (CET)

2020

Genovis and Glykos partner to enable new ADC platform [regulatory release]2020-12-10 15:29 (CET)
Communiqué from Genovis AB (publ) Annual General Meeting May 5, 2020 [regulatory release]2020-05-05 15:40 (CEST)
Genovis acquires all shares in QED Bioscience Inc., San Diego, CA, USA [regulatory release]2020-04-29 15:59 (CEST)
Genovis AB publish Annual Report 2019 [regulatory release]2020-04-14 15:19 (CEST)
NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB [regulatory release]2020-03-30 10:03 (CEST)
Nomination Committee proposes Torben Jørgensen for new chairman of Genovis [regulatory release]2020-03-23 09:03 (CET)
Genovis intends to acquire QED Bioscience and conduct a rights issue of SEK 50 million [regulatory release]2020-02-20 13:02 (CET)
Genovis AB (publ) to publish 2020 reports ahead of schedule [regulatory release]2020-01-31 13:13 (CET)

2019

COMMUNIQUÉ FROM EXTRAORDINARY GENERAL MEETING FOR GENOVIS AB (PUBL) DECEMBER 20, 2019 [regulatory release]2019-12-20 12:59 (CET)
Genovis launches Immobilized SialEXO[®]for efficient biopharmaceutical sample preparation [regulatory release]2019-12-10 12:15 (CET)
Genovis AB (publ) announces Extraordinary General Meeting [regulatory release]2019-12-04 10:05 (CET)
Genovis receives order worth about SEK 13 million [regulatory release]2019-08-19 12:05 (CEST)
Genovis AB hires CFO [regulatory release]2019-06-19 10:42 (CEST)
Genovis launches SialEXO®23 to enhance glycan research2019-05-28 12:52 (CEST)
Communiqué from Genovis AB (publ) Annual General Meeting May 23, 2019 [regulatory release]2019-05-23 20:58 (CEST)
Genovis signs distribution agreement with FUJIFILM Wako Pure Chemical for Japan, Taiwan and Singapore markets [regulatory release]2019-05-16 12:36 (CEST)
Principal shareholder of Genovis reduced his holdings2019-05-09 12:29 (CEST)
NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB [regulatory release]2019-04-15 16:41 (CEST)
Proposal to expand the Genovis Board of Directors at 2019 Annual General Meeting [regulatory release]2019-04-10 09:52 (CEST)
Genovis and Thermo Fisher Scientific Announces Collaboration to Advance Biopharmaceutical Characterization and Monitoring Workflows [regulatory release]2019-04-08 14:10 (CEST)

2018

Genovis certified to ISO 9001:2015 [regulatory release]2018-11-08 13:57 (CET)
Genovis launches FabRICATOR®-HPLC for automated antibody analysis [regulatory release]2018-09-18 13:34 (CEST)
Genovis further expands marketing organization [regulatory release]2018-07-05 11:03 (CEST)
Communiqué from Genovis AB (publ) Annual General Meeting May 17, 2018 [regulatory release]2018-05-17 20:48 (CEST)
Genovis carries out directed share issue to raise SEK 10.1 million for the company [regulatory release]2018-04-29 22:21 (CEST)
Genovis launches GlycOCATCH™ for purification of O-glycosylated proteins [regulatory release]2018-04-26 11:45 (CEST)
Genovis strengthens its marketing organization in the US [regulatory release]2018-04-24 10:34 (CEST)
Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting [regulatory release]2018-04-23 08:40 (CEST)
Genovis signs distribution agreement for South Korean market [regulatory release]2018-04-06 11:49 (CEST)
NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB [regulatory release]2018-04-05 14:22 (CEST)
Genovis AB (publ) postpone publication of the Year-end Report 2017 [regulatory release]2018-02-14 08:28 (CET)

2017

Genovis signs distribution agreement in India [regulatory release]2017-12-08 13:25 (CET)
Genovis signs distribution agreement with Shanghai Titan Scientific Ltd. [regulatory release]2017-11-07 13:47 (CET)
Genovis signs distribution agreement with Chinese Beijing Zhongyuan Ltd. [regulatory release]2017-09-18 11:58 (CEST)
Genovis expands its product portfolio and launches three products for glycan analysis [regulatory release]2017-05-30 09:17 (CEST)
Communiqué from Genovis AB (publ) Annual General Meeting May 11, 2017 [regulatory release]2017-05-12 08:05 (CEST)
Genovis expands its product portfolio and launches FabALACTICA™ [regulatory release]2017-05-02 08:15 (CEST)
NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB [regulatory release]2017-04-10 11:09 (CEST)
Genovis carries out directed share issue to raise SEK 11.5 million for the company [regulatory release]2017-04-10 09:00 (CEST)
Genovis AB initiates sales of GlyCLICK™ [regulatory release]2017-04-04 14:22 (CEST)

2016

GENOVIS IS CHANGING CERTIFIED ADVISER [regulatory release]2016-11-21 12:21 (CET)
Genovis signs license agreement with Life Technologies Corporation [regulatory release]2016-10-11 09:32 (CEST)
Genovis and Promega sign global license agreement and settle litigation [regulatory release]2016-06-30 08:13 (CEST)
Genovis rights issue oversubscribed [regulatory release]2016-06-13 12:37 (CEST)
Genovis launches FabULOUS®Fab kit [regulatory release]2016-06-03 13:41 (CEST)
Genovis publish a new share issue prospectus [regulatory release]2016-05-16 10:03 (CEST)
Press release from Genovis AB (publ) Annual General Meeting May 12, 2016 [regulatory release]2016-05-13 08:08 (CEST)
Genovis launches GingisREX™ and expands product portfolio [regulatory release]2016-04-14 14:58 (CEST)
Notice of Annual General Meeting [regulatory release]2016-04-08 11:07 (CEST)
The Board of Directors of Genovis AB (publ) has resolved on a rights issue subject to approval by the Annual General Meeting on May 12, 2016 [regulatory release]2016-03-21 12:51 (CET)
Genovis AB has signed a strategic cooperation agreement with Alphalyse A/S [regulatory release]2016-03-17 09:43 (CET)

2015

Genovis launches new enzyme product [regulatory release]2015-12-03 12:10 (CET)
Genovis AB (publ) to publish Q3 2015 report ahead of schedule [regulatory release]2015-10-23 09:58 (CEST)
Genovis is reorganizing and closing its subsidiary GeccoDots [regulatory release]2015-09-25 13:35 (CEST)
Genovis rights issue oversubscribed by 63 % [regulatory release]2015-06-04 12:59 (CEST)
Genovis to present data from mAbCHECK™ system on ASMS June 4. [regulatory release]2015-06-03 13:15 (CEST)
Press release from Genovis AB (publ) Annual General Meeting May 5, 2015 [regulatory release]2015-05-06 08:04 (CEST)
Genovis launches a follow-up to FabRICATOR® [regulatory release]2015-05-05 11:23 (CEST)
Genovis’ founder Sarah Fredriksson proposed new Chairperson of the company – Vice President Fredrik Olsson appointed new CEO [regulatory release]2015-05-04 11:28 (CEST)
Genovis AB (publ) to publish Q1 2015 report ahead of schedule [regulatory release]2015-04-10 11:37 (CEST)
Notice to the Annual General Meeting in Genovis AB (publ) [regulatory release]2015-04-01 13:20 (CEST)
The Board of Directors of Genovis AB (publ) resolves on fully underwritten rights issue and reschedules Annual General Meeting to May 5, 2015 [regulatory release]2015-04-01 13:10 (CEST)
Genovis is launching a new enzyme product [regulatory release]2015-03-12 09:13 (CET)
Genovis introduces a new service concept [regulatory release]2015-03-06 12:36 (CET)

2014

Genovis establishes subsidiary in the US [regulatory release]2014-12-11 11:15 (CET)
Genovis’ project for automatic analysis with the FabRICATOR® enzyme shows proof-of-concept [regulatory release]2014-12-09 15:11 (CET)
Genovis AB sues US company for patent infringement [regulatory release]2014-11-11 08:20 (CET)
COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) May 20, 2014 [regulatory release]2014-05-21 08:05 (CEST)
Genovis AB (publ) Annual General Meeting [regulatory release]2014-04-22 06:36 (CEST)
Genovis switches to pure direct sales of all products in the US [regulatory release]2014-03-05 11:01 (CET)
Date change for Annual General Meeting [regulatory release]2014-02-14 15:32 (CET)
Genovis to publish Year-end Report 2013 ahead of schedule [regulatory release]2014-02-10 11:05 (CET)
Genovis’ Board of Directors has decided upon a private placement [regulatory release]2014-01-17 11:53 (CET)

2013

Genovis rights issue oversubscribed [regulatory release]2013-12-19 12:14 (CET)
Genovis was granted SEK 1 million in research support from VINNOVA [regulatory release]2013-12-11 14:21 (CET)
Genovis publish a new share issue prospectus [regulatory release]2013-11-21 08:59 (CET)
COMMUNIQUÉ FROM EXTRAORDINARY GENERAL MEETING FOR GENOVIS AB (PUBL) NOVEMBER 19, 2013 [regulatory release]2013-11-20 09:12 (CET)
Genovis’ board of directors resolves to issue new shares and announces Extraordinary General Meeting [regulatory release]2013-11-04 11:34 (CET)
Date change for Genovis AB January-September 2013 interim report [regulatory release]2013-10-29 13:57 (CET)
Genovis launches GlycINATOR™ for analysis of antibody molecules [regulatory release]2013-10-21 10:50 (CEST)
Genovis to launch FabULOUS™ for analysis and characterization of antibody molecules [regulatory release]2013-10-15 11:10 (CEST)
Genovis’ subsidiary GeccoDots introduces groundbreaking product and presents pipeline project results [regulatory release]2013-09-09 10:05 (CEST)
Genovis evaluates new technology for early diagnosis of cardiovascular disease [regulatory release]2013-08-14 09:00 (CEST)
Genovis is moving to new premises [regulatory release]2013-06-13 10:09 (CEST)
Communiqué from Annual General Meeting for Genovis AB (publ) April 25, 20132013-04-26 08:40 (CEST)
Genovis rights issue oversubscribed [regulatory release]2013-04-22 11:17 (CEST)
Genovis to publish Q1 2013 report ahead of schedule [regulatory release]2013-04-10 12:42 (CEST)
Genovis’ 2012 Annual Report Published [regulatory release]2013-04-09 13:59 (CEST)
Genovis receives SEK 1.575 million from VINNOVA [regulatory release]2013-03-26 11:21 (CET)
Notice of Annual General Meeting of Genovis AB (publ) [regulatory release]2013-03-21 12:10 (CET)
Genovis signs agreement on projects for major pharmaceutical company [regulatory release]2013-03-20 10:44 (CET)
Genovis’ Board of Directors decides on rights issue [regulatory release]2013-02-19 11:47 (CET)

2012

Genovis to publish Q3 2012 report ahead of schedule [regulatory release]2012-11-08 10:49 (CET)
Genovis strengthens organization with international sales manager [regulatory release]2012-07-03 11:00 (CEST)
Genovis Signs Exclusive Distribution Agreement with Sigma-Aldrich® for Sales in Asia, Southeast Asia and South America [regulatory release]2012-06-29 09:56 (CEST)
Genovis completes private placement of shares to LMK Venture AB [regulatory release]2012-05-28 12:44 (CEST)
Genovis’ rights issue fully subscribed [regulatory release]2012-05-22 11:09 (CEST)
Genovis launches FabRICATOR® 96-well plate for high throughput applications [regulatory release]2012-05-21 09:59 (CEST)
Genovis to publish Q2 2012 report ahead of schedule [regulatory release]2012-05-18 10:17 (CEST)
Genovis to publish Q1 2012 report ahead of schedule [regulatory release]2012-04-23 10:49 (CEST)
Genovis publish a new share issue prospectus [regulatory release]2012-03-28 11:43 (CEST)
GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) March 20, 2012 [regulatory release]2012-03-21 09:50 (CET)
Notice of Annual General Meeting of Genovis AB (publ) [regulatory release]2012-02-20 12:27 (CET)
Genovis’ nanoparticle project published in prestigious Journal of Nuclear Medicine [regulatory release]2012-02-13 11:06 (CET)
Date change for Annual General Meeting and reports [regulatory release]2012-02-07 11:11 (CET)

2011

Genovis AB nomination committee appointed [regulatory release]2011-11-24 16:16 (CET)
GENOVIS: COMMUNIQUÉ FROM EXTRA GENERAL MEETING, JULY 21, 2011 [regulatory release]2011-07-22 09:00 (CEST)
Notice of Extra General Meeting of Genovis AB (publ) [regulatory release]2011-07-06 13:16 (CEST)
Genovis has a new majority owner [regulatory release]2011-06-23 09:35 (CEST)
GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) June 9, 2011 [regulatory release]2011-06-10 11:23 (CEST)
Nomination Committee Proposal for 2011 Board of Directors [regulatory release]2011-05-19 09:02 (CEST)
GENOVIS RIGHTS ISSUE 91% SUBSCRIBED [regulatory release]2011-05-12 11:35 (CEST)
Notice of Annual General Meeting of Genovis AB (publ)2011-05-10 20:49 (CEST)
Genovis will attend several conferences in May –June 2011 [regulatory release]2011-05-04 12:44 (CEST)
New Product Release [regulatory release]2011-04-20 12:06 (CEST)
Genovis 2010 Annual Report is Published [regulatory release]2011-04-06 14:54 (CEST)
Genovis publish a new share issue prospectus [regulatory release]2011-04-04 16:08 (CEST)
Report from the extraordinary general meeting of Genovis AB (publ) [regulatory release]2011-03-29 09:16 (CEST)
AGM postponed and the January-March Interim Report rescheduled [regulatory release]2011-03-28 15:25 (CEST)
Notice of Extra General Meeting of Genovis AB (publ) [regulatory release]2011-03-09 09:48 (CET)
Genovis’ board of directors to convene EGM and recommend that the meeting resolve to issue new shares [regulatory release]2011-03-07 15:46 (CET)
Genovis AB nomination committee appointed [regulatory release]2011-02-21 09:57 (CET)
Genovis acquires exclusive license for upconverting nanoparticles and plans launch within 1 year [regulatory release]2011-02-16 14:08 (CET)
Genovis year-end report delayed [regulatory release]2011-02-14 14:10 (CET)